JP2009530392A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009530392A5 JP2009530392A5 JP2009501558A JP2009501558A JP2009530392A5 JP 2009530392 A5 JP2009530392 A5 JP 2009530392A5 JP 2009501558 A JP2009501558 A JP 2009501558A JP 2009501558 A JP2009501558 A JP 2009501558A JP 2009530392 A5 JP2009530392 A5 JP 2009530392A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- salt
- cancer
- formula
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 22
- 150000003839 salts Chemical class 0.000 claims 19
- 239000011780 sodium chloride Substances 0.000 claims 19
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- 108010050749 geranylgeranyltransferase type-I Proteins 0.000 claims 5
- 229910052801 chlorine Inorganic materials 0.000 claims 4
- 239000000460 chlorine Substances 0.000 claims 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- 230000002401 inhibitory effect Effects 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 4
- 108010006731 Dimethylallyltranstransferase Proteins 0.000 claims 3
- 102000005454 Dimethylallyltranstransferase Human genes 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 239000003112 inhibitor Substances 0.000 claims 3
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 2
- 206010017758 Gastric cancer Diseases 0.000 claims 2
- 206010024324 Leukaemias Diseases 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 206010033128 Ovarian cancer Diseases 0.000 claims 2
- 208000008443 Pancreatic Carcinoma Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 125000004432 carbon atoms Chemical group C* 0.000 claims 2
- 239000003966 growth inhibitor Substances 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 201000002528 pancreatic cancer Diseases 0.000 claims 2
- 201000011549 stomach cancer Diseases 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 102000035365 modified proteins Human genes 0.000 claims 1
- 108091005569 modified proteins Proteins 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- IJIDXGMALIJKGB-UHFFFAOYSA-N CCOC(CNC(Cc1ccccc1)C(OC)=O)=O Chemical compound CCOC(CNC(Cc1ccccc1)C(OC)=O)=O IJIDXGMALIJKGB-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78444306P | 2006-03-22 | 2006-03-22 | |
| PCT/US2007/007135 WO2007111948A2 (en) | 2006-03-22 | 2007-03-22 | Inhibitors of protein prenyltransferases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009530392A JP2009530392A (ja) | 2009-08-27 |
| JP2009530392A5 true JP2009530392A5 (US20040106767A1-20040603-C00005.png) | 2010-05-20 |
Family
ID=38541651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009501558A Pending JP2009530392A (ja) | 2006-03-22 | 2007-03-22 | タンパク質プレニルトランスフェラーゼの阻害剤 |
Country Status (7)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6777217B1 (en) | 1996-03-26 | 2004-08-17 | President And Fellows Of Harvard College | Histone deacetylases, and uses related thereto |
| US20030129724A1 (en) | 2000-03-03 | 2003-07-10 | Grozinger Christina M. | Class II human histone deacetylases, and uses related thereto |
| CA2937005A1 (en) | 2005-03-22 | 2006-09-28 | President And Fellows Of Harvard College | Treatment of protein degradation disorders |
| AU2007345292B2 (en) | 2006-02-14 | 2013-10-31 | Dana-Farber Cancer Institute, Inc. | Bifunctional histone deacetylase inhibitors |
| CN101431996A (zh) | 2006-03-22 | 2009-05-13 | 加利福尼亚大学董事会 | 蛋白质异戊二烯基转移酶的抑制剂 |
| US8304451B2 (en) * | 2006-05-03 | 2012-11-06 | President And Fellows Of Harvard College | Histone deacetylase and tubulin deacetylase inhibitors |
| CA2731730C (en) | 2008-07-23 | 2017-06-13 | President And Fellows Of Harvard College | Deacetylase inhibitors and uses thereof |
| US9125821B2 (en) | 2008-07-28 | 2015-09-08 | The Regents Of The University Of California | Nanodrug targeting protein geranylgeranylation |
| US20110178138A1 (en) | 2008-07-28 | 2011-07-21 | The Regents Of The University Of California | Inhibitors of protein prenyltransferases |
| WO2011019393A2 (en) | 2009-08-11 | 2011-02-17 | President And Fellows Of Harvard College | Class- and isoform-specific hdac inhibitors and uses thereof |
| WO2012097371A2 (en) * | 2011-01-14 | 2012-07-19 | The Regents Of The University Of California | Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis |
| WO2012116181A2 (en) * | 2011-02-24 | 2012-08-30 | The Regents Of The University Of California | Small molecules for endothelial cell activation |
| DK2707031T3 (da) * | 2011-05-08 | 2019-10-07 | Legochem Biosciences Inc | Protein-active agent conjugates and method for preparing the same |
| US20150087628A1 (en) * | 2012-04-10 | 2015-03-26 | The Regents Of The University Of California | Compositions and methods for treating cancer |
| WO2019076269A1 (zh) | 2017-10-16 | 2019-04-25 | 清华大学 | 甲羟戊酸通路抑制剂及其药物组合物 |
| CN112574041B (zh) * | 2020-12-25 | 2022-10-28 | 温州大学新材料与产业技术研究院 | 一种手性β羟基1,3-二羰基类化合物的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4559157A (en) * | 1983-04-21 | 1985-12-17 | Creative Products Resource Associates, Ltd. | Cosmetic applicator useful for skin moisturizing |
| LU84979A1 (fr) * | 1983-08-30 | 1985-04-24 | Oreal | Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux |
| US4820508A (en) * | 1987-06-23 | 1989-04-11 | Neutrogena Corporation | Skin protective composition |
| US4992478A (en) * | 1988-04-04 | 1991-02-12 | Warner-Lambert Company | Antiinflammatory skin moisturizing composition and method of preparing same |
| US4938949A (en) * | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| AU2003259717A1 (en) | 2002-08-07 | 2004-02-25 | Bristol-Myers Squibb Company | Modulators of rabggt and methods of use thereof |
| CA2528652A1 (en) * | 2003-06-19 | 2004-12-23 | Pfizer Products Inc. | Nk1 antagonist |
| CN101431996A (zh) | 2006-03-22 | 2009-05-13 | 加利福尼亚大学董事会 | 蛋白质异戊二烯基转移酶的抑制剂 |
-
2007
- 2007-03-22 CN CNA2007800144909A patent/CN101431996A/zh active Pending
- 2007-03-22 JP JP2009501558A patent/JP2009530392A/ja active Pending
- 2007-03-22 WO PCT/US2007/007135 patent/WO2007111948A2/en active Application Filing
- 2007-03-22 US US12/293,993 patent/US8093274B2/en not_active Expired - Fee Related
- 2007-03-22 EP EP07753739A patent/EP2007383A4/en not_active Withdrawn
- 2007-03-22 CA CA002647038A patent/CA2647038A1/en not_active Abandoned
- 2007-03-22 AU AU2007229457A patent/AU2007229457A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009530392A5 (US20040106767A1-20040603-C00005.png) | ||
| Liu et al. | Synthesis and in vitro study of pseudo-peptide thioureas containing α-aminophosphonate moiety as potential antitumor agents | |
| ES2524119T3 (es) | Furazanobencimidazoles como profármacos para tratar enfermedades neoplásicas o autoinmunes | |
| JP2008535902A5 (US20040106767A1-20040603-C00005.png) | ||
| TW200716518A (en) | Acetylene derivatives | |
| MX2010008101A (es) | Derivados de indol 2-carboxamidas y de azaindol 2-carboxamidas sustituidos con un silanilo, su preparacion y su aplicacion en terapeutica. | |
| JP2009515980A5 (US20040106767A1-20040603-C00005.png) | ||
| EA200970311A1 (ru) | ПРОИЗВОДНЫЕ 2-АРИЛ-6-ФЕНИЛИМИДАЗО[1,2-α]ПИРИДИНОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ | |
| MX2010007977A (es) | Derivados de carboxamidas azabiciclicas, su preparacion y su aplicacion en terapeutica. | |
| RU2008123839A (ru) | Соединение оксазола и фармацевтическая композиция | |
| EP2268604B1 (en) | Therapies for cancer using isotopically substituted lysine | |
| CA2565660A1 (en) | Ortho substituted aryl or heteroaryl amide compounds | |
| RU2020102453A (ru) | Фармацевтические композиции | |
| JP2014500870A5 (US20040106767A1-20040603-C00005.png) | ||
| MX2010003156A (es) | Derivados de aril amida substituida con tetrazol y usos de los mismos. | |
| CY1113873T1 (el) | Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90 | |
| RS20080002A (en) | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof | |
| DK2061452T3 (da) | Anvendelse af koffeinsyre og derivater deraf mod cancer | |
| RU2011134283A (ru) | Имидазотиазольные производные, имеющие пролиновую циклическую структуру | |
| JP2004190075A5 (US20040106767A1-20040603-C00005.png) | ||
| JP2012513982A5 (US20040106767A1-20040603-C00005.png) | ||
| MX2009002905A (es) | Derivados de 3-amino-piridina para el tratamiento de trastornos metabolicos. | |
| BRPI0519948A2 (pt) | composto, processo para a preparação de um composto, composição farmacêutica e método de tratamento de cáncer em um mamìfero | |
| JP2009534449A5 (US20040106767A1-20040603-C00005.png) | ||
| JP2010500971A5 (US20040106767A1-20040603-C00005.png) |
